Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

History and Perspectives of A2AAdenosine Receptor Antagonists as Potential Therapeutic Agents
Delia Preti, Pier Giovanni Baraldi, Allan R. Moorman, et al.
Medicinal Research Reviews (2015) Vol. 35, Iss. 4, pp. 790-848
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Pharmacology of Adenosine Receptors: The State of the Art
Pier Andrea Borea, Stefania Gessi, Stefania Merighi, et al.
Physiological Reviews (2018) Vol. 98, Iss. 3, pp. 1591-1625
Open Access | Times Cited: 621
Purinergic signalling in brain ischemia
Felicita Pedata, Ilaria Dettori, Elisabetta Coppi, et al.
Neuropharmacology (2015) Vol. 104, pp. 105-130
Closed Access | Times Cited: 146
Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
Bayard R. Huck, Lisa Kötzner, Klaus Urbahns
Angewandte Chemie International Edition (2017) Vol. 57, Iss. 16, pp. 4412-4428
Open Access | Times Cited: 133
Pathological overproduction: the bad side of adenosine
Pier Andrea Borea, Stefania Gessi, Stefania Merighi, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 13, pp. 1945-1960
Open Access | Times Cited: 108
Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances
Eslam M.H. Ali, Mohammed S. Abdel‐Maksoud, Chang‐Hyun Oh
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 7, pp. 1159-1194
Closed Access | Times Cited: 93
The Role of Adenosine Receptors in Psychostimulant Addiction
Inmaculada Ballesteros‐Yáñez, Carlos Alberto Castillo, Stefania Merighi, et al.
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 85
Purinergic receptors in psychiatric disorders
Ute Krügel
Neuropharmacology (2015) Vol. 104, pp. 212-225
Closed Access | Times Cited: 90
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields
Katia Varani, Fabrizio Vincenzi, Annalisa Ravani, et al.
Mediators of Inflammation (2017) Vol. 2017, pp. 1-11
Open Access | Times Cited: 85
Ligand modulation of sidechain dynamics in a wild-type human GPCR
Lindsay Clark, Igor Dikiy, Karen Chapman, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 83
Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy
Samaneh Arab, Jamshid Hadjati
Immune Network (2019) Vol. 19, Iss. 4
Open Access | Times Cited: 73
Structurally Enabled Discovery of Adenosine A2A Receptor Antagonists
Ali Jazayeri, Stephen P. Andrews, Fiona H. Marshall
Chemical Reviews (2016) Vol. 117, Iss. 1, pp. 21-37
Closed Access | Times Cited: 71
Adenosine receptor antagonists: Recent advances and therapeutic perspective
Anjali Saini, Rajiv Patel, Sobhi Gaba, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113907-113907
Closed Access | Times Cited: 49
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455
Stefania Gessi, Serena Bencivenni, Enrica Battistello, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 58
Role and Function of A2A and A3 Adenosine Receptors in Patients with Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid Arthritis
Annalisa Ravani, Fabrizio Vincenzi, Alessandra Bortoluzzi, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 4, pp. 697-697
Open Access | Times Cited: 56
Targeting adenosine A2A receptor antagonism for treatment of cancer
Miles Congreve, Giles A. Brown, Alexandra Borodovsky, et al.
Expert Opinion on Drug Discovery (2018) Vol. 13, Iss. 11, pp. 997-1003
Closed Access | Times Cited: 53
High-throughput in situ X-ray screening of and data collection from protein crystals at room temperature and under cryogenic conditions
Jana Broecker, Takefumi Morizumi, Wei‐Lin Ou, et al.
Nature Protocols (2018) Vol. 13, Iss. 2, pp. 260-292
Closed Access | Times Cited: 52
Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinson’s Disease: A Recent Update and Challenge
Jiyue Zheng, Xiaohu Zhang, Xuechu Zhen
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 2, pp. 783-791
Closed Access | Times Cited: 52
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity
Flavia Varano, Daniela Catarzi, Fabrizio Vincenzi, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 23, pp. 10564-10576
Open Access | Times Cited: 51
A2A Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction
Gabriela Hurtado‐Alvarado, Emilio Domı́nguez-Salazar, Javier Velázquez‐Moctezuma, et al.
PLoS ONE (2016) Vol. 11, Iss. 11, pp. e0167236-e0167236
Open Access | Times Cited: 48
Caffeine: A Multifunctional Efficacious Molecule with Diverse Health Implications and Emerging Delivery Systems
Xinjie Song, Mahendra Singh, Kyung Eun Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12003-12003
Open Access | Times Cited: 5
Biochemical and Pharmacological Role of A1 Adenosine Receptors and Their Modulation as Novel Therapeutic Strategy
Katia Varani, Fabrizio Vincenzi, Stefania Merighi, et al.
Advances in experimental medicine and biology (2017), pp. 193-232
Open Access | Times Cited: 42
Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging
Aren van Waarde, Rudi Dierckx, Xiaoyun Zhou, et al.
Medicinal Research Reviews (2017) Vol. 38, Iss. 1, pp. 5-56
Open Access | Times Cited: 40
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease
Stefania Gessi, Tino Emanuele Poloni, G Negro, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2344-2344
Open Access | Times Cited: 29
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases
Stefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 24, pp. 4138-4151
Open Access | Times Cited: 28
Allosteric Interactions between Adenosine A2A and Dopamine D2 Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging
Kavya Prasad, Erik F. J. de Vries, Philip H. Elsinga, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1719-1719
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top